
2023-2029 Global Hyperimmune Globulin Injection Industry Research & Trends Analysis Report
Hyperimmune Globulin Injection Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest Study , the global market for Hyperimmune Globulin Injection should grow from US$ 1867 million in 2023 to US$ 2839.8 million by 2030, with a CAGR of 6.2% for the period of 2024-2030.
China Hyperimmune Globulin Injection market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Hyperimmune Globulin Injection market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, Hepatitis B Immunoglobulins segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Government Institution has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2030.
The global key manufacturers of Hyperimmune Globulin Injection include CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG and Hualan Bio, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
This report aims to provide a comprehensive study of the global market for Hyperimmune Globulin Injection. Report Highlights:
(1) Global Hyperimmune Globulin Injection market size (sales volume & revenue), history data from 2019-2024 and forecast data from 2024 to 2030.
(2) Global Hyperimmune Globulin Injection market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(3) China Hyperimmune Globulin Injection market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(4) Global Hyperimmune Globulin Injection segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Hyperimmune Globulin Injection segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Hyperimmune Globulin Injection, capacity, production and trends.
(7) Hyperimmune Globulin Injection industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Rho(D) Immunoglobulins
Other
Market segment by application, can be divided into
Government Institution
Private Sector
Others
Market segment by players, this report covers
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
1 Market Overview
1.1 Hyperimmune Globulin Injection Definition
1.2 Global Hyperimmune Globulin Injection Market Size and Forecast
1.2.1 By Revenue, Global Hyperimmune Globulin Injection Market Size, 2019-2030
1.2.2 By Sales Volume, Global Hyperimmune Globulin Injection Market Size, 2019-2030
1.2.3 Global Hyperimmune Globulin Injection Price Trend, 2019-2030
1.3 China Hyperimmune Globulin Injection Market Size and Forecast
1.3.1 By Revenue, China Hyperimmune Globulin Injection Market Size, 2019-2030
1.3.2 By Sales Volume, China Hyperimmune Globulin Injection Market Size, 2019-2030
1.3.3 China Hyperimmune Globulin Injection Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Hyperimmune Globulin Injection Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China Hyperimmune Globulin Injection Share in Global Market, 2019-2030
1.4.3 Hyperimmune Globulin Injection Market Size: China VS Global, 2019-2030
1.5 Hyperimmune Globulin Injection Market Dynamics
1.5.1 Hyperimmune Globulin Injection Market Drivers
1.5.2 Hyperimmune Globulin Injection Market Restraints
1.5.3 Hyperimmune Globulin Injection Industry Trends
1.5.4 Hyperimmune Globulin Injection Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Hyperimmune Globulin Injection Revenue by Company, 2019-2024
2.2 Global Hyperimmune Globulin Injection Sales Volume by Company, 2019-2024
2.3 Global Hyperimmune Globulin Injection Price by Company, 2019-2024
2.4 Global Hyperimmune Globulin Injection Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Hyperimmune Globulin Injection Concentration Ratio
2.6 Global Hyperimmune Globulin Injection Mergers & Acquisitions, Expansion Plans
2.7 Global Hyperimmune Globulin Injection Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Hyperimmune Globulin Injection Revenue by Company, 2019-2024
3.2 China Hyperimmune Globulin Injection Sales Volume by Company, 2019-2024
3.3 China Hyperimmune Globulin Injection Hyperimmune Globulin Injection Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Hyperimmune Globulin Injection Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)
3.5 Chinese Local Players, Hyperimmune Globulin Injection Domestic VS Export
3.6 China Market, Hyperimmune Globulin Injection Import & Export
3.6.1 China Market, Hyperimmune Globulin Injection Import & Export, 2019-2030
3.6.2 China Hyperimmune Globulin Injection Import & Export Trends
3.6.3 Main Sources of China Hyperimmune Globulin Injection Import
3.6.4 Export Destination of China Hyperimmune Globulin Injection
4 Hyperimmune Globulin Injection Production by Region
4.1 Global Hyperimmune Globulin Injection Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of Hyperimmune Globulin Injection Manufacturers
4.3 Global Major Manufacturers, Hyperimmune Globulin Injection Capacity Expansion and Future Plans
4.4 Global Hyperimmune Globulin Injection Capacity by Region
4.5 Global Hyperimmune Globulin Injection Production by Region
4.5.1 Global Hyperimmune Globulin Injection Production & Forecast by Region, 2019 VS 2023 VS 2030
4.5.2 Global Hyperimmune Globulin Injection Production by Region, 2019-2024
4.5.3 Global Hyperimmune Globulin Injection Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Hyperimmune Globulin Injection Industry Chain
5.2 Hyperimmune Globulin Injection Upstream Analysis
5.2.1 Hyperimmune Globulin Injection Core Raw Materials
5.2.2 Main Manufacturers of Hyperimmune Globulin Injection Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Hyperimmune Globulin Injection Production Mode
5.6 Hyperimmune Globulin Injection Procurement Model
5.7 Hyperimmune Globulin Injection Industry Sales Model and Sales Channels
5.7.1 Hyperimmune Globulin Injection Sales Model
5.7.2 Hyperimmune Globulin Injection Typical Distributors
6 Sights by Type
6.1 Hyperimmune Globulin Injection Classification
6.1.1 Hepatitis B Immunoglobulins
6.1.2 Rabies Immunoglobulins
6.1.3 Tetanus Immunoglobulins
6.1.4 Rho(D) Immunoglobulins
6.1.5 Other
6.2 By Type, Global Hyperimmune Globulin Injection Market Size & CAGR, 2019 VS 2023 VS 2030
6.3 By Type, Global Hyperimmune Globulin Injection Revenue, 2019-2030
6.4 By Type, Global Hyperimmune Globulin Injection Sales Volume, 2019-2030
6.5 By Type, Global Hyperimmune Globulin Injection Price, 2019-2030
7 Sights by Application
7.1 Hyperimmune Globulin Injection Segment by Application
7.1.1 Government Institution
7.1.2 Private Sector
7.1.3 Others
7.2 By Application, Global Hyperimmune Globulin Injection Market Size & CAGR, 2019 VS 2023 VS 2030
7.3 By Application, Global Hyperimmune Globulin Injection Revenue, 2019-2030
7.4 By Application, Global Hyperimmune Globulin Injection Sales Volume, 2019-2030
7.5 By Application, Global Hyperimmune Globulin Injection Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Hyperimmune Globulin Injection Market Size, 2019 VS 2023 VS 2030
8.2 By Region, Global Hyperimmune Globulin Injection Revenue, 2019-2030
8.3 By Region, Global Hyperimmune Globulin Injection Sales Volume, 2019-2030
8.4 North America
8.4.1 North America Hyperimmune Globulin Injection Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America Hyperimmune Globulin Injection Market Size Market Share
8.5 Europe
8.5.1 Europe Hyperimmune Globulin Injection Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Hyperimmune Globulin Injection Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Hyperimmune Globulin Injection Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Hyperimmune Globulin Injection Market Size Market Share
8.7 South America
8.7.1 South America Hyperimmune Globulin Injection Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Hyperimmune Globulin Injection Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Hyperimmune Globulin Injection Market Size & CAGR,2019 VS 2023 VS 2030
9.2 By Country, Global Hyperimmune Globulin Injection Revenue, 2019-2030
9.3 By Country, Global Hyperimmune Globulin Injection Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S. Hyperimmune Globulin Injection Market Size, 2019-2030
9.4.2 By Company, U.S. Hyperimmune Globulin Injection Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Hyperimmune Globulin Injection Market Size, Share, 2023 VS 2030
9.4.4 By Application, U.S. Hyperimmune Globulin Injection Market Size, Share, 2023 VS 2030
9.5 Europe
9.5.1 Europe Hyperimmune Globulin Injection Market Size, 2019-2030
9.5.2 By Company, Europe Hyperimmune Globulin Injection Sales Volume Market Share, 2022
9.5.3 By Type, Europe Hyperimmune Globulin Injection Market Size, Share, 2023 VS 2030
9.5.4 By Application, Europe Hyperimmune Globulin Injection Market Size, Share, 2023 VS 2030
9.6 China
9.6.1 China Hyperimmune Globulin Injection Market Size, 2019-2030
9.6.2 By Company, China Hyperimmune Globulin Injection Sales Volume Market Share, 2022
9.6.3 By Type, China Hyperimmune Globulin Injection Market Size, Share, 2023 VS 2030
9.6.4 By Application, China Hyperimmune Globulin Injection Market Size, Share, 2023 VS 2030
9.7 Japan
9.7.1 Japan Hyperimmune Globulin Injection Market Size, 2019-2030
9.7.2 By Company, Japan Hyperimmune Globulin Injection Sales Volume Market Share, 2022
9.7.3 By Type, Japan Hyperimmune Globulin Injection Market Size, Share, 2023 VS 2030
9.7.4 By Application, Japan Hyperimmune Globulin Injection Market Size, Share, 2023 VS 2030
9.8 South Korea
9.8.1 South Korea Hyperimmune Globulin Injection Market Size, 2019-2030
9.8.2 By Company, South Korea Hyperimmune Globulin Injection Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Hyperimmune Globulin Injection Market Size, Share, 2023 VS 2030
9.8.4 By Application, South Korea Hyperimmune Globulin Injection Market Size, Share, 2023 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia Hyperimmune Globulin Injection Market Size, 2019-2030
9.9.2 By Company, Southeast Asia Hyperimmune Globulin Injection Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Hyperimmune Globulin Injection Market Size, Share, 2023 VS 2030
9.9.4 By Application, Southeast Asia Hyperimmune Globulin Injection Market Size, Share, 2023 VS 2030
9.10 India
9.10.1 India Hyperimmune Globulin Injection Market Size, 2019-2030
9.10.2 By Company, India Hyperimmune Globulin Injection Sales Volume Market Share, 2022
9.10.3 By Type, India Hyperimmune Globulin Injection Market Size, Share, 2023 VS 2030
9.10.4 By Application, India Hyperimmune Globulin Injection Market Size, Share, 2023 VS 2030
9.11 Middle East & Asia
9.11.1 Middle East & Asia Hyperimmune Globulin Injection Market Size, 2019-2030
9.11.2 By Company, Middle East & Asia Hyperimmune Globulin Injection Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Hyperimmune Globulin Injection Market Size, Share, 2023 VS 2030
9.11.4 By Application, Middle East & Asia Hyperimmune Globulin Injection Market Size, Share, 2023 VS 2030
10 Manufacturers Profile
10.1 CSL Behring
10.1.1 CSL Behring Company Information, Head Office, Market Area and Industry Position
10.1.2 CSL Behring Hyperimmune Globulin Injection Models, Specifications and Application
10.1.3 CSL Behring Hyperimmune Globulin Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.1.4 CSL Behring Company Profile and Main Business
10.1.5 CSL Behring Recent Developments
10.2 Grifols
10.2.1 Grifols Company Information, Head Office, Market Area and Industry Position
10.2.2 Grifols Hyperimmune Globulin Injection Models, Specifications and Application
10.2.3 Grifols Hyperimmune Globulin Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.2.4 Grifols Company Profile and Main Business
10.2.5 Grifols Recent Developments
10.3 Biotest
10.3.1 Biotest Company Information, Head Office, Market Area and Industry Position
10.3.2 Biotest Hyperimmune Globulin Injection Models, Specifications and Application
10.3.3 Biotest Hyperimmune Globulin Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Biotest Company Profile and Main Business
10.3.5 Biotest Recent Developments
10.4 Kedrion
10.4.1 Kedrion Company Information, Head Office, Market Area and Industry Position
10.4.2 Kedrion Hyperimmune Globulin Injection Models, Specifications and Application
10.4.3 Kedrion Hyperimmune Globulin Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Kedrion Company Profile and Main Business
10.4.5 Kedrion Recent Developments
10.5 CBPO
10.5.1 CBPO Company Information, Head Office, Market Area and Industry Position
10.5.2 CBPO Hyperimmune Globulin Injection Models, Specifications and Application
10.5.3 CBPO Hyperimmune Globulin Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.5.4 CBPO Company Profile and Main Business
10.5.5 CBPO Recent Developments
10.6 Emergent (Cangene)
10.6.1 Emergent (Cangene) Company Information, Head Office, Market Area and Industry Position
10.6.2 Emergent (Cangene) Hyperimmune Globulin Injection Models, Specifications and Application
10.6.3 Emergent (Cangene) Hyperimmune Globulin Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Emergent (Cangene) Company Profile and Main Business
10.6.5 Emergent (Cangene) Recent Developments
10.7 Kamada
10.7.1 Kamada Company Information, Head Office, Market Area and Industry Position
10.7.2 Kamada Hyperimmune Globulin Injection Models, Specifications and Application
10.7.3 Kamada Hyperimmune Globulin Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Kamada Company Profile and Main Business
10.7.5 Kamada Recent Developments
10.8 CNBG
10.8.1 CNBG Company Information, Head Office, Market Area and Industry Position
10.8.2 CNBG Hyperimmune Globulin Injection Models, Specifications and Application
10.8.3 CNBG Hyperimmune Globulin Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.8.4 CNBG Company Profile and Main Business
10.8.5 CNBG Recent Developments
10.9 Hualan Bio
10.9.1 Hualan Bio Company Information, Head Office, Market Area and Industry Position
10.9.2 Hualan Bio Hyperimmune Globulin Injection Models, Specifications and Application
10.9.3 Hualan Bio Hyperimmune Globulin Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.9.4 Hualan Bio Company Profile and Main Business
10.9.5 Hualan Bio Recent Developments
10.10 Shanghai RAAS
10.10.1 Shanghai RAAS Company Information, Head Office, Market Area and Industry Position
10.10.2 Shanghai RAAS Hyperimmune Globulin Injection Models, Specifications and Application
10.10.3 Shanghai RAAS Hyperimmune Globulin Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.10.4 Shanghai RAAS Company Profile and Main Business
10.10.5 Shanghai RAAS Recent Developments
10.11 Sichuan Yuanda Shuyang
10.11.1 Sichuan Yuanda Shuyang Company Information, Head Office, Market Area and Industry Position
10.11.2 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Models, Specifications and Application
10.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.11.4 Sichuan Yuanda Shuyang Company Profile and Main Business
10.11.5 Sichuan Yuanda Shuyang Recent Developments
10.12 ADMA Biologics
10.12.1 ADMA Biologics Company Information, Head Office, Market Area and Industry Position
10.12.2 ADMA Biologics Hyperimmune Globulin Injection Models, Specifications and Application
10.12.3 ADMA Biologics Hyperimmune Globulin Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.12.4 ADMA Biologics Company Profile and Main Business
10.12.5 ADMA Biologics Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
Table 1. Hyperimmune Globulin Injection Market Size & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Hyperimmune Globulin Injection Market Restraints
Table 3. Hyperimmune Globulin Injection Market Trends
Table 4. Hyperimmune Globulin Injection Industry Policy
Table 5. Global Hyperimmune Globulin Injection Revenue by Company, 2019-2024, US$ million
Table 6. Global Hyperimmune Globulin Injection Revenue Market Share by Company, 2019-2024
Table 7. Global Hyperimmune Globulin Injection Sales Volume by Company, 2019-2024, (K Units)
Table 8. Global Hyperimmune Globulin Injection Sales Volume Market Share by Company, 2019-2024
Table 9. Global Hyperimmune Globulin Injection Price by Company, 2019-2024, (US$/Unit)
Table 10. Global Hyperimmune Globulin Injection Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Hyperimmune Globulin Injection Mergers & Acquisitions, Expansion Plans
Table 12. Global Hyperimmune Globulin Injection Manufacturers Product Type
Table 13. China Hyperimmune Globulin Injection Revenue by Company, 2019-2024, US$ million
Table 14. China Hyperimmune Globulin Injection Revenue Market Share by Company, 2019-2024
Table 15. China Hyperimmune Globulin Injection Sales Volume by Company, 2019-2024, (K Units)
Table 16. China Hyperimmune Globulin Injection Sales Volume Market Share by Company, 2019-2024
Table 17. China Market, Hyperimmune Globulin Injection Production, Sales, Import and Export, 2019-2030, (K Units)
Table 18. China Hyperimmune Globulin Injection Import & Export Trends
Table 19. Main Sources of China Hyperimmune Globulin Injection Import
Table 20. Export Destination of China Hyperimmune Globulin Injection
Table 21. Global Headquarters and Manufacturing Base of Hyperimmune Globulin Injection Manufacturers
Table 22. Global Major Manufacturers, Hyperimmune Globulin Injection Capacity Expansion and Future Plans
Table 23. Global Hyperimmune Globulin Injection Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 24. Global Hyperimmune Globulin Injection Production by Region, 2019-2024, (K Units)
Table 25. Global Hyperimmune Globulin Injection Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Hyperimmune Globulin Injection Upstream (Raw Materials)
Table 27. Global Hyperimmune Globulin Injection Typical Customers
Table 28. Hyperimmune Globulin Injection Typical Distributors
Table 29. By Type, Global Hyperimmune Globulin Injection Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Application, Global Hyperimmune Globulin Injection Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 31. By Region, Global Hyperimmune Globulin Injection Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 32. By Region, Global Hyperimmune Globulin Injection Revenue, 2019-2030, US$ Million
Table 33. By Region, Global Hyperimmune Globulin Injection Sales Volume, 2019-2030, (K Units)
Table 34. By Country, Global Hyperimmune Globulin Injection Revenue & CAGR,2019 VS 2024 VS 2030, US$ Million
Table 35. By Country, Global Hyperimmune Globulin Injection Revenue, 2019-2030, US$ Million
Table 36. By Country, Global Hyperimmune Globulin Injection Revenue Market Share, 2019-2030
Table 37. By Country, Global Hyperimmune Globulin Injection Sales Volume, 2019-2030, (K Units)
Table 38. By Country, Global Hyperimmune Globulin Injection Sales Volume Market Share, 2019-2030
Table 39. CSL Behring Company Information, Head Office, Market Area and Industry Position
Table 40. CSL Behring Hyperimmune Globulin Injection Models, Specifications and Application
Table 41. CSL Behring Hyperimmune Globulin Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. CSL Behring Company Profile and Main Business
Table 43. CSL Behring Recent Developments
Table 44. Grifols Company Information, Head Office, Market Area and Industry Position
Table 45. Grifols Hyperimmune Globulin Injection Models, Specifications and Application
Table 46. Grifols Hyperimmune Globulin Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. Grifols Company Profile and Main Business
Table 48. Grifols Recent Developments
Table 49. Biotest Company Information, Head Office, Market Area and Industry Position
Table 50. Biotest Hyperimmune Globulin Injection Models, Specifications and Application
Table 51. Biotest Hyperimmune Globulin Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. Biotest Company Profile and Main Business
Table 53. Biotest Recent Developments
Table 54. Kedrion Company Information, Head Office, Market Area and Industry Position
Table 55. Kedrion Hyperimmune Globulin Injection Models, Specifications and Application
Table 56. Kedrion Hyperimmune Globulin Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. Kedrion Company Profile and Main Business
Table 58. Kedrion Recent Developments
Table 59. CBPO Company Information, Head Office, Market Area and Industry Position
Table 60. CBPO Hyperimmune Globulin Injection Models, Specifications and Application
Table 61. CBPO Hyperimmune Globulin Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. CBPO Company Profile and Main Business
Table 63. CBPO Recent Developments
Table 64. Emergent (Cangene) Company Information, Head Office, Market Area and Industry Position
Table 65. Emergent (Cangene) Hyperimmune Globulin Injection Models, Specifications and Application
Table 66. Emergent (Cangene) Hyperimmune Globulin Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 67. Emergent (Cangene) Company Profile and Main Business
Table 68. Emergent (Cangene) Recent Developments
Table 69. Kamada Company Information, Head Office, Market Area and Industry Position
Table 70. Kamada Hyperimmune Globulin Injection Models, Specifications and Application
Table 71. Kamada Hyperimmune Globulin Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 72. Kamada Company Profile and Main Business
Table 73. Kamada Recent Developments
Table 74. CNBG Company Information, Head Office, Market Area and Industry Position
Table 75. CNBG Hyperimmune Globulin Injection Models, Specifications and Application
Table 76. CNBG Hyperimmune Globulin Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 77. CNBG Company Profile and Main Business
Table 78. CNBG Recent Developments
Table 79. Hualan Bio Company Information, Head Office, Market Area and Industry Position
Table 80. Hualan Bio Hyperimmune Globulin Injection Models, Specifications and Application
Table 81. Hualan Bio Hyperimmune Globulin Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 82. Hualan Bio Company Profile and Main Business
Table 83. Hualan Bio Recent Developments
Table 84. Shanghai RAAS Company Information, Head Office, Market Area and Industry Position
Table 85. Shanghai RAAS Hyperimmune Globulin Injection Models, Specifications and Application
Table 86. Shanghai RAAS Hyperimmune Globulin Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 87. Shanghai RAAS Company Profile and Main Business
Table 88. Shanghai RAAS Recent Developments
Table 89. Sichuan Yuanda Shuyang Company Information, Head Office, Market Area and Industry Position
Table 90. Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Models, Specifications and Application
Table 91. Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 92. Sichuan Yuanda Shuyang Company Profile and Main Business
Table 93. Sichuan Yuanda Shuyang Recent Developments
Table 94. ADMA Biologics Company Information, Head Office, Market Area and Industry Position
Table 95. ADMA Biologics Hyperimmune Globulin Injection Models, Specifications and Application
Table 96. ADMA Biologics Hyperimmune Globulin Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 97. ADMA Biologics Company Profile and Main Business
Table 98. ADMA Biologics Recent Developments
List of Figure
Figure 1. Hyperimmune Globulin Injection Picture
Figure 2. By Revenue, Global Hyperimmune Globulin Injection Market Size and Forecast, 2019-2030, US$ Million
Figure 3. By Sales Volume, Global Hyperimmune Globulin Injection Market Size and Forecast, 2019-2030, (K Units)
Figure 4. Global Hyperimmune Globulin Injection Price Trend, 2019-2030, (US$/Unit)
Figure 5. By Revenue, China Hyperimmune Globulin Injection Market Size and Forecast, 2019-2030, US$ million
Figure 6. By Sales Volume, China Hyperimmune Globulin Injection Market Size and Forecast, 2019-2030, (K Units)
Figure 7. China Hyperimmune Globulin Injection Price Trend, 2019-2030 (US$/Unit)
Figure 8. By Revenue, China Hyperimmune Globulin Injection Share of Global Market, 2019-2030
Figure 9. By Sales Volume, China Hyperimmune Globulin Injection Share of Global Market, 2019-2030
Figure 10. Global Hyperimmune Globulin Injection Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Hyperimmune Globulin Injection Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Hyperimmune Globulin Injection Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Hyperimmune Globulin Injection Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Hyperimmune Globulin Injection Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 15. Chinese Local Players, Proportion of Hyperimmune Globulin Injection Domestic VS Export, 2022
Figure 16. Global Hyperimmune Globulin Injection Capacity, Production and Capacity Utilization, 2019-2030
Figure 17. Global Hyperimmune Globulin Injection Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Hyperimmune Globulin Injection Production Market Share & Forecast by Region, 2019-2030
Figure 19. Hyperimmune Globulin Injection Industry Chain
Figure 20. Hyperimmune Globulin Injection Procurement Model
Figure 21. Hyperimmune Globulin Injection Sales Model
Figure 22. Hyperimmune Globulin Injection Sales Channels, Direct Sales and Distribution
Figure 23. Hepatitis B Immunoglobulins
Figure 24. Rabies Immunoglobulins
Figure 25. Tetanus Immunoglobulins
Figure 26. Rho(D) Immunoglobulins
Figure 27. Other
Figure 28. By Type, Global Hyperimmune Globulin Injection Revenue, 2019-2030, US$ Million
Figure 29. By Type, Global Hyperimmune Globulin Injection Revenue Market Share, 2019-2030
Figure 30. By Type, Global Hyperimmune Globulin Injection Sales Volume, 2019-2030, (K Units)
Figure 31. By Type, Global Hyperimmune Globulin Injection Sales Volume Market Share, 2019-2030
Figure 32. By Type, Global Hyperimmune Globulin Injection Price, 2019-2030, (US$/Unit)
Figure 33. Government Institution
Figure 34. Private Sector
Figure 35. Others
Figure 36. By Application, Global Hyperimmune Globulin Injection Revenue, 2019-2030, US$ Million
Figure 37. By Application, Global Hyperimmune Globulin Injection Revenue Market Share, 2019-2030
Figure 38. By Application, Global Hyperimmune Globulin Injection Sales Volume, 2019-2030, (K Units)
Figure 39. By Application, Global Hyperimmune Globulin Injection Sales Volume Market Share, 2019-2030
Figure 40. By Application, Global Hyperimmune Globulin Injection Price, 2019-2030, (US$/Unit)
Figure 41. By Region, Global Hyperimmune Globulin Injection Revenue Market Share, 2019-2030
Figure 42. By Region, Global Hyperimmune Globulin Injection Sales Volume Market Share, 2019-2030
Figure 43. North America Hyperimmune Globulin Injection Revenue & Forecasts, 2019-2030, US$ Million
Figure 44. By Country, North America Hyperimmune Globulin Injection Revenue Market Share, 2022
Figure 45. Europe Hyperimmune Globulin Injection Revenue & Forecasts, 2019-2030, US$ Million
Figure 46. By Country, Europe Hyperimmune Globulin Injection Revenue Market Share, 2022
Figure 47. Asia Pacific Hyperimmune Globulin Injection Revenue & Forecasts, 2019-2030, US$ Million
Figure 48. By Country/Region, Asia Pacific Hyperimmune Globulin Injection Revenue Market Share, 2022
Figure 49. South America Hyperimmune Globulin Injection Revenue & Forecasts, 2019-2030, US$ Million
Figure 50. By Country, South America Hyperimmune Globulin Injection Revenue Market Share, 2022
Figure 51. Middle East & Africa Hyperimmune Globulin Injection Revenue & Forecasts, 2019-2030, US$ Million
Figure 52. U.S. Hyperimmune Globulin Injection Sales Volume, 2019-2030, (K Units)
Figure 53. By Company, U.S. Hyperimmune Globulin Injection Market Share, 2022
Figure 54. By Type, U.S. Hyperimmune Globulin Injection Sales Volume Market Share, 2022 VS 2029
Figure 55. By Application, U.S. Hyperimmune Globulin Injection Sales Volume Market Share, 2022 VS 2029
Figure 56. Europe Hyperimmune Globulin Injection Sales Volume, 2019-2030, (K Units)
Figure 57. By Company, Europe Hyperimmune Globulin Injection Market Share, 2022
Figure 58. By Type, Europe Hyperimmune Globulin Injection Sales Volume Market Share, 2022 VS 2029
Figure 59. By Application, Europe Hyperimmune Globulin Injection Sales Volume Market Share, 2022 VS 2029
Figure 60. China Hyperimmune Globulin Injection Sales Volume, 2019-2030, (K Units)
Figure 61. By Company, China Hyperimmune Globulin Injection Market Share, 2022
Figure 62. By Type, China Hyperimmune Globulin Injection Sales Volume Market Share, 2022 VS 2029
Figure 63. By Application, China Hyperimmune Globulin Injection Sales Volume Market Share, 2022 VS 2029
Figure 64. Japan Hyperimmune Globulin Injection Sales Volume, 2019-2030, (K Units)
Figure 65. By Company, Japan Hyperimmune Globulin Injection Market Share, 2022
Figure 66. By Type, Japan Hyperimmune Globulin Injection Sales Volume Market Share, 2022 VS 2029
Figure 67. By Application, Japan Hyperimmune Globulin Injection Sales Volume Market Share, 2022 VS 2029
Figure 68. South Korea Hyperimmune Globulin Injection Sales Volume, 2019-2030, (K Units)
Figure 69. By Company, South Korea Hyperimmune Globulin Injection Market Share, 2022
Figure 70. By Type, South Korea Hyperimmune Globulin Injection Sales Volume Market Share, 2022 VS 2029
Figure 71. By Application, South Korea Hyperimmune Globulin Injection Sales Volume Market Share, 2022 VS 2029
Figure 72. Southeast Asia Hyperimmune Globulin Injection Sales Volume, 2019-2030, (K Units)
Figure 73. By Company, Southeast Asia Hyperimmune Globulin Injection Market Share, 2022
Figure 74. By Type, Southeast Asia Hyperimmune Globulin Injection Sales Volume Market Share, 2022 VS 2029
Figure 75. By Application, Southeast Asia Hyperimmune Globulin Injection Sales Volume Market Share, 2022 VS 2029
Figure 76. India Hyperimmune Globulin Injection Sales Volume, 2019-2030, (K Units)
Figure 77. By Company, India Hyperimmune Globulin Injection Market Share, 2022
Figure 78. By Type, India Hyperimmune Globulin Injection Sales Volume Market Share, 2022 VS 2029
Figure 79. By Application, India Hyperimmune Globulin Injection Sales Volume Market Share, 2022 VS 2029
Figure 80. Middle East & Asia Hyperimmune Globulin Injection Sales Volume, 2019-2030, (K Units)
Figure 81. By Company, Middle East & Asia Hyperimmune Globulin Injection Market Share, 2022
Figure 82. By Type, Middle East & Asia Hyperimmune Globulin Injection Sales Volume Market Share, 2022 VS 2029
Figure 83. By Application, Middle East & Asia Hyperimmune Globulin Injection Sales Volume Market Share, 2022 VS 2029
Figure 84. Research Methodology
Figure 85. Breakdown of Primary Interviews
Figure 86. Bottom-up Approaches
Figure 87. Top-down Approaches
Research Methodology:
Hyperimmune Globulin Injection Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|